Desh Rakshak Aushdhalaya Ltd. specializes in Pharmaceuticals within the Healthcare sector.
Desh Rakshak Aushdhalaya Ltd., with Security Code 531521, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 24.86 | 1.63 | 24.86 | 0.37 | -7.14 | - | -1.07 | 2.42 |
2023-10-01 | 2023-12-31 | 15.80 | 1.33 | 16.23 | 0.30 | -2.20 | 0.43 | -1.10 | 1.33 |
2023-07-01 | 2023-09-30 | 8.35 | 0.90 | 8.35 | 0.20 | -2.26 | - | -1.10 | 0.90 |
2023-04-01 | 2023-06-30 | 11.06 | 0.83 | 11.06 | 0.19 | -2.17 | - | -1.10 | 0.83 |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 2% |
3 Years: | -3% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 5% |
3 Years: | 1% |
TTM: | -7% |
Stock Price CAGR | |
---|---|
10 Years: | 2% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | 54% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
1 Year: | 0% |
DRAL's Ghaziabad unit has been awarded the ISO 9001:2015 certification by TUV SUD South Asia Private Limited for its Quality Management System.
DRAL and IIT Delhi have signed a Memorandum of Understanding (MoU) to establish a collaborative research and development program.
DRAL has received a significant order from the Indian Army for the supply of a range of critical medicines.